Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Erik Harris currently holds 49,960 shares of Ultragenyx Pharmaceutical Inc. (RARE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Erik Harris has been a net seller of RARE stock. They have purchased $0 and sold $1.8M worth of shares.
Erik Harris's most recent insider trade was on Apr 16, 2026, when they sold 49,960 shares at $0.00 per share.
Erik Harris serves as Executive at Ultragenyx Pharmaceutical Inc. (RARE). They have executed 43 insider transactions totaling $1.8M over their tenure at the company.
Erik Harris holds the position of Executive at Ultragenyx Pharmaceutical Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Erik Harris has shown a selling trading pattern, with $0 in total purchases and $1.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Erik Harris was on Mar 1, 2021, when they sold $341.3K worth of RARE shares. This transaction involved 2,470 shares at $138.17 per share.
Erik Harris currently owns 49,960 shares of Ultragenyx Pharmaceutical Inc. (RARE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Erik Harris's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Erik Harris has 43 Form 4 filings on record as an insider at Ultragenyx Pharmaceutical Inc..
Set alerts for Erik Harris and 40,000+ other insiders.